The Federal Register http://thefederalregister.com/b.p/agency/National_Institutes_of_Health/2007-12-10/ Daily Publications of Meetings and Rules Changes for the Federal Government Tue, Oct 7 2008 11:00:00 GMT Tue, Oct 7 2008 11:00:00 GMT info@thefederalregister.com <![CDATA[ National Institute of Allergy and Infectious Diseases; Division of Acquired Immunodeficiency Syndrome--AIDS Vaccine]]> http://thefederalregister.com/d.p/2007-12-10-E7-23844

The AIDS Vaccine Research Working Group (AVRWG) will hold a meeting on Wednesday, December 12, 2007, at the William F. Bolger Center, North Building, Benjamin Franklin Hall, 9600 Newbridge Road, Potomac, Maryland 20854, from 8:30 a.m. to approximately 4:30 p.m.

The working group will provide technical input on the (1) results from the STEP trial and their implication for HIV vaccine development, (2) priorities for additional analyses of data and specimens from the trial, and (3) further development of the DNA+Ad5 candidate of the NIAID Vaccine Research Center.

For further information concerning this meeting contact Dr. James Bradac, Division of AIDS, National Institute of Allergy and Infectious Diseases, Room 5116, MSC7620, 6700B Rockledge Drive, Bethesda, MD 208927620, Telephone: (301) 4353754, FAX: (301) 4023684, Email:
jbradac@niaid.nih.gov.

Dated: November 28, 2007.
James Bradac,
Division of AIDS, NIAID, National Institutes of Health. ]]> http://thefederalregister.com/d.p/2007-12-10-E7-23844 Mon, Dec 10 2007 11:00:00 GMT <![CDATA[ National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting]]> http://thefederalregister.com/d.p/2007-12-10-07-5979

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group, Clinical and Treatment
Subcommittee.

Date: March 45, 2008.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Katrina L. Foster, PhD, Scientific Review Admi ]]> http://thefederalregister.com/d.p/2007-12-10-07-5979 Mon, Dec 10 2007 11:00:00 GMT